CoChat

A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial.

Open access
Chalder, M, Wiles, NJ, Campbell, J, Hollinghurst, SP, Searle, A, Haase, AM, Taylor, AH, Fox, KR, Baxter, H, Davis, M, Thorp, H, Winder, R, Wright, C, Calnan, M, Lawlor, DA, Peters, TJ, Sharp, DJ, Turner, KM, Montgomery, AA, Lewis, G · 2012 · Health Technology Assessment

The DOI matches its Crossref record; 71 of the 74 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The TREAting Depression with physical activity (TREAD) study investigated the cost-effectiveness of a physical activity intervention, in addition to usual general practitioner care, as a treatment for people with depression. DESIGN: An individually randomised, pragmatic, multicentre randomised controlled trial with follow-up at 4, 8 and 12 months. A subset of participants took part in a qualitative study that investigated the acceptability and perceived benefits of the intervention. SETTING: General practices in the Bristol and Exeter areas. PARTICIPANTS: Aged 18-69 years with an International Statistical Classification of Diseases and Related Health Problems, 10th Edition (ICD-10) diagnosis of depression and scoring ≥ 14 on the Beck Depression Inventory (BDI). Those who were unable to complete self-administered questionnaires in English, with medical contraindications to physical activity or with psychosis, bipolar disorder or serious drug abuse were excluded. INTERVENTIONS: We devised an intervention designed to encourage choice and autonomy in the adoption of physical activity. It consisted of up to three face-to-face and ten telephone contacts delivered by a trained physical activity facilitator over an 8-month period. MAIN OUTCOME MEASURES: The primary outcome was the BDI score measured at 4 months. Secondary outcomes included depressive symptoms over the 12 months and quality of life, antidepressant use and level of physical activity. RESULTS: The study recruited 361 patients, with 182 randomised to the intervention arm and 179 to the usual care arm; there was 80% retention at the 4-month follow-up. The intervention group had a slightly lower BDI score at 4 months [-0.54, 95% confidence interval (CI) -3.06 to 1.99] but there was no evidence that the intervention improved outcome for depression. Neither was there any evidence to suggest a difference in the prescription of or self-reported use of antidepressants. However, the amount of physical activity undertaken by those who had received the intervention was increased (odds ratio 2.3, 95% CI 1.3 to 3.9) and was sustained beyond the end of the intervention. From a health-care perspective, the intervention group was more costly than the usual care group, with the cost of the intervention £220 per person on average. It is therefore extremely unlikely that the intervention is cost-effective as a treatment for depression using current willingness-to-pay thresholds. CONCLUSIONS: This physical activity intervention is very unlikely to lead to any clinical benefit in terms of depressive symptoms or to be a cost-effective treatment for depression. Previous research has reported some benefit and there are three possible reasons for this discrepancy: first, even though the intervention increased self-reported physical activity, the increase in activity was not sufficiently large to lead to a measurable influence; second, only more vigorous activity might be of benefit; and third, previous studies had recruited individuals with a pre-existing commitment to physical activity. Future research is needed to identify and explain the mechanisms by which depression might be effectively treated, including, in particular, specific guidance on the optimum type, intensity and duration of physical activity required to produce a therapeutic effect. TRIAL REGISTRATION: Current Controlled Trials ISRCTN16900744. FUNDING: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 16, No. 10. See the HTA programme website for further project information.

Overview

Integrity signals

Registry

Crossref · 10.3310/hta16100

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 72

Metadata

Authors
Chalder, M., Wiles, N., Campbell, J., Hollinghurst, S., Searle, A., Haase, A., Taylor, A., Fox, K., Baxter, H., Davis, M., Thorp, H., Winder, R., Wright, C., Calnan, M., Lawlor, D., Peters, T., Sharp, D., Turner, K., Montgomery, A., & Lewis, G.
Affiliations
  • University of Bristol (GB)
  • University of Exeter (GB)
  • University of Kent (GB)
Corresponding author
Lewis, G
Venue
Health Technology Assessment
Published
2012-03
Volume
16
Issue
10
Pages
1-164, iii
ISSN
  • 1366-5278 (ISSN-L)
  • 2046-4924
OpenAlex
W2148958707
Cited by
71
References
74
Citations by year
2026: 4 · 2025: 2 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 9 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 7 · 2014: 5 · 2013: 10 · 2012: 4
FWCI
5.57
Type
journal article
Language
en
Open access
Locations
  • Health Technology Assessment (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Open Research Exeter (University of Exeter) (publishedVersion)
  • Explore Bristol Research (publishedVersion, other-oa)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion)
  • Bristol Research (University of Bristol) (submittedVersion, other-oa)
Funders
Health Technology Assessment programme (03/45/07)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
depression, physical activity interventions, cost-effectiveness, telephone-delivered intervention, facilitators of physical activity, general practitioner care, antidepressant use, quality of life, physical activity level, acceptability of interventions, primary care depression treatment, health care costs, Beck Depression Inventory
MeSH terms
Adolescent, Adult, Aged, Antidepressive Agents, Behavior Therapy, Cost-Benefit Analysis, Depression, Exercise Therapy, Female, Humans, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Patients, Time Factors, Health Care Costs, Young Adult, General Practitioners

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.